A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15634649

Download in:

View as

General Info

PMID
15634649